Literature DB >> 18196211

The laminated hearts.

Friedrich C Luft1.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18196211     DOI： 10.1007/s00109-007-0297-8

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN： 0946-2716            Impact factor:   4.599


× No keyword cloud information.
  8 in total

Review 1.  A-type lamins: guardians of the soma?

Authors:  Chris J Hutchison; Howard J Worman
Journal:  Nat Cell Biol       Date:  2004-11       Impact factor: 28.824

2.  Primary prevention of sudden death in patients with lamin A/C gene mutations.

Authors:  Christophe Meune; Jop H Van Berlo; Frédéric Anselme; Gisèle Bonne; Yigal M Pinto; Denis Duboc
Journal:  N Engl J Med       Date:  2006-01-12       Impact factor: 91.245

Review 3.  Messenger RNA surveillance systems monitoring proper translation termination.

Authors:  Nobuyoshi Akimitsu
Journal:  J Biochem       Date:  2007-11-01       Impact factor: 3.387

Review 4.  Mouse models of the laminopathies.

Authors:  Colin L Stewart; Serguei Kozlov; Loren G Fong; Stephen G Young
Journal:  Exp Cell Res       Date:  2007-03-31       Impact factor: 3.905

Review 5.  Phenomics and lamins: from disease to therapy.

Authors:  Robert A Hegele; Junko Oshima
Journal:  Exp Cell Res       Date:  2007-03-30       Impact factor: 3.905

Review 6.  Lamin A/C and cardiac diseases.

Authors:  Nicolas Sylvius; Frédérique Tesson
Journal:  Curr Opin Cardiol       Date:  2006-05       Impact factor: 2.161

7.  Incomplete nonsense-mediated decay of mutant lamin A/C mRNA provokes dilated cardiomyopathy and ventricular tachycardia.

Authors:  Stephanie K Geiger; Harald Bär; Philipp Ehlermann; Sarah Wälde; Désirée Rutschow; Raphael Zeller; Boris T Ivandic; Hanswalter Zentgraf; Hugo A Katus; Harald Herrmann; Dieter Weichenhan
Journal:  J Mol Med (Berl)       Date:  2007-11-07       Impact factor: 4.599

Review 8.  "Laminopathies": a wide spectrum of human diseases.

Authors:  Howard J Worman; Gisèle Bonne
Journal:  Exp Cell Res       Date:  2007-03-30       Impact factor: 3.905
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.